| Indication | For treatment of severe infections caused by susceptible bacteria. |
| Pharmacodynamics | Cephaloglycin is an antibiotic related to cephalosporin but no longer in common use. It is an orally absorbed derivative of cephalosporin C. |
| Mechanism of action | The bactericidal activity of cephaloglycin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). |
| Absorption | Well absorbed following oral administration. |
| Volume of distribution | Not Available |
| Protein binding | Not Available |
| Metabolism | Not Available |
| Route of elimination | Not Available |
| Half life | Not Available |
| Clearance | Not Available |
| Toxicity | Adverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions. |
No comments:
Post a Comment